A Randomized Controlled Trial of the Effect of Liposomal Bupivacaine (Exparel) When Compared to Saline Control in Reducing Opioid Utilization for Pain Management in Postoperative Lumbar Spine Surgeries.
Latest Information Update: 15 Jun 2023
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postpartum pain
- Focus Therapeutic Use
- 08 Dec 2022 Status changed from recruiting to completed.
- 20 Oct 2021 Status changed from not yet recruiting to recruiting.
- 10 Mar 2021 Planned initiation date changed from 1 Jan 2021 to 1 Apr 2021.